Mersana Therapeutics(MRSN)

1.9692 -0.0608 -2.9951%

今开:2.06昨收:2.03
最高:2.11 最低:1.945
涨停价:0.0跌停价:0.0
总市值:2.40953746E8

Mersana Therapeutics的热门讨论

季度财报

Mersana Therapeutics(MRSN)05-09 21:05

$Mersana Therapeutics(MRSN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-24-021985  Act: 34  Size: 5 MB 网页链接查看全文

持股变动声明

Mersana Therapeutics(MRSN)06-13 04:55

$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070894  Size: 5 KB 网页链接查看全文

持股变动声明

Mersana Therapeutics(MRSN)06-13 04:55

$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070896  Size: 5 KB 网页链接查看全文

超过5%股东持股披露

Mersana Therapeutics(MRSN)05-17 20:35

$Mersana Therapeutics(MRSN)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-062787  Act: 34  Size: 110 KB 网页链接查看全文

持股变动声明

Mersana Therapeutics(MRSN)07-03 04:35

$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-077365  Size: 5 KB 网页链接查看全文

当期报告

Mersana Therapeutics(MRSN)05-09 19:15

$Mersana Therapeutics(MRSN)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001104659-24-059104  Act: 34  Size: 246 KB 网页链接查看全文

招股说明书

Mersana Therapeutics(MRSN)05-10 05:15

$Mersana Therapeutics(MRSN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-24-059428  Act: 33  Size: 367 KB 网页链接查看全文

当期报告

Mersana Therapeutics(MRSN)06-12 04:35

$Mersana Therapeutics(MRSN)$ 8-K Current report, item 5.07 Accession Number: 0001104659-24-070408  Act: 34  Size: 206 KB 网页链接查看全文

持股变动声明

Mersana Therapeutics(MRSN)06-13 04:55

$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070892  Size: 5 KB 网页链接查看全文

持股变动声明

Mersana Therapeutics(MRSN)06-13 04:55

$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070900  Size: 5 KB 网页链接查看全文

1 2

Mersana Therapeutics的最新讨论

淘沙见金2018-06-03 12:45

有空可以看看 $Mersana Therapeutics, Inc.(MRSN)$ 的数据,早期了一些不该应该比Daiichi Sankyo的DS-8201在安全性方面好一些。查看全文

群氓鄙陋2018-05-16 10:10

$$Zymeworks Inc.(ZYME)$ $Mersana Therapeutics, Inc.(MRSN)$ $Immunomedics, Inc. (IMMU)$ 乳腺癌药物美股标的Mark!谢谢楼主的无私分享查看全文

淘沙见金2018-05-15 12:06

$$Zymeworks Inc.(ZYME)$ $Mersana Therapeutics, Inc.(MRSN)$ $Immunomedics, Inc. (IMMU)$ 今年ASCO乳腺癌重点关注的几家。其中ZYME的HER2靶向双特异性抗体和MRSN的XMT-1522是重点关注的对象。查看全文

iam双手反拍2017-10-13 15:03

$Mersana Therapeutics, Inc.(MRSN)$ 在新一代ADC技术的道路上,美国的Mersana并非独行者和技术垄断者。我国的诺灵生物医药科技(北京)有限公司(简称“诺灵”)也掌握了高分子偶联技术,其自主知识产权的技术平台与Mersana相比,不但毫不逊色,而且在药物代谢控制、药物释放方面更优。诺灵的ADC...查看全文

iam双手反拍2017-10-13 14:29

$Mersana Therapeutics, Inc.(MRSN)$
“在新一代ADC技术的道路上,美国的Mersana并非独行者和技术垄断者。我国的诺灵生物医药科技(北京)有限公司(简称“诺灵”)也掌握了高分子偶联技术,其自主知识产权的技术平台与Mersana相比,不但毫不逊色,而且在药物代谢控制、药物释放方面更优。诺灵...查看全文

1 2 3 4 5

Mersana Therapeutics的公告

持股变动声明

$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-077365  Size: 5 KB 网页链接

持股变动声明

$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-072570  Size: 5 KB 网页链接

持股变动声明

$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070892  Size: 5 KB 网页链接

持股变动声明

$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070894  Size: 5 KB 网页链接

持股变动声明

$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070895  Size: 5 KB 网页链接

持股变动声明

$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070898  Size: 5 KB 网页链接

持股变动声明

$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070896  Size: 5 KB 网页链接

持股变动声明

$Mersana Therapeutics(MRSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070900  Size: 5 KB 网页链接

当期报告

$Mersana Therapeutics(MRSN)$ 8-K Current report, item 5.07 Accession Number: 0001104659-24-070408  Act: 34  Size: 206 KB 网页链接

超过5%股东持股披露

$Mersana Therapeutics(MRSN)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-062787  Act: 34  Size: 110 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51